460 related articles for article (PubMed ID: 26468525)
1. The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.
Quinn LL; Williams LR; White C; Forrest C; Zuo J; Rowe M
J Virol; 2016 Jan; 90(1):356-67. PubMed ID: 26468525
[TBL] [Abstract][Full Text] [Related]
2. The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules.
Keating S; Prince S; Jones M; Rowe M
J Virol; 2002 Aug; 76(16):8179-88. PubMed ID: 12134023
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways.
Zuo J; Quinn LL; Tamblyn J; Thomas WA; Feederle R; Delecluse HJ; Hislop AD; Rowe M
J Virol; 2011 Feb; 85(4):1604-14. PubMed ID: 21123379
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation.
Zuo J; Currin A; Griffin BD; Shannon-Lowe C; Thomas WA; Ressing ME; Wiertz EJ; Rowe M
PLoS Pathog; 2009 Jan; 5(1):e1000255. PubMed ID: 19119421
[TBL] [Abstract][Full Text] [Related]
5. Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation.
Fares S; Spiess K; Olesen ETB; Zuo J; Jackson S; Kledal TN; Wills MR; Rosenkilde MM
mBio; 2019 Jan; 10(1):. PubMed ID: 30647152
[TBL] [Abstract][Full Text] [Related]
6. Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.
Croft NP; Shannon-Lowe C; Bell AI; Horst D; Kremmer E; Ressing ME; Wiertz EJ; Middeldorp JM; Rowe M; Rickinson AB; Hislop AD
PLoS Pathog; 2009 Jun; 5(6):e1000490. PubMed ID: 19557156
[TBL] [Abstract][Full Text] [Related]
7. Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle.
Quinn LL; Zuo J; Abbott RJ; Shannon-Lowe C; Tierney RJ; Hislop AD; Rowe M
PLoS Pathog; 2014 Aug; 10(8):e1004322. PubMed ID: 25144360
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.
Zuo J; Thomas WA; Haigh TA; Fitzsimmons L; Long HM; Hislop AD; Taylor GS; Rowe M
PLoS Pathog; 2011 Dec; 7(12):e1002455. PubMed ID: 22216005
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
[TBL] [Abstract][Full Text] [Related]
10. EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail.
Griffin BD; Gram AM; Mulder A; Van Leeuwen D; Claas FH; Wang F; Ressing ME; Wiertz E
J Immunol; 2013 Feb; 190(4):1672-84. PubMed ID: 23315076
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
Albanese M; Tagawa T; Bouvet M; Maliqi L; Lutter D; Hoser J; Hastreiter M; Hayes M; Sugden B; Martin L; Moosmann A; Hammerschmidt W
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6467-E6475. PubMed ID: 27698133
[TBL] [Abstract][Full Text] [Related]
12. Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle.
Williams LR; Quinn LL; Rowe M; Zuo J
J Virol; 2016 Jan; 90(2):947-58. PubMed ID: 26537677
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and -independent mechanisms: implications for oncogenesis.
Zuo J; Hislop AD; Leung CS; Sabbah S; Rowe M
J Virol; 2013 May; 87(10):5340-50. PubMed ID: 23449805
[TBL] [Abstract][Full Text] [Related]
14. Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection.
Ressing ME; Keating SE; van Leeuwen D; Koppers-Lalic D; Pappworth IY; Wiertz EJ; Rowe M
J Immunol; 2005 Jun; 174(11):6829-38. PubMed ID: 15905524
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of heavy chain and beta2-microglobulin synthesis as a mechanism of major histocompatibility complex class I downregulation during Epstein-Barr virus replication.
Guerreiro-Cacais AO; Uzunel M; Levitskaya J; Levitsky V
J Virol; 2007 Feb; 81(3):1390-400. PubMed ID: 17108039
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication.
Brulois K; Toth Z; Wong LY; Feng P; Gao SJ; Ensser A; Jung JU
J Virol; 2014 Aug; 88(16):9335-49. PubMed ID: 24899205
[TBL] [Abstract][Full Text] [Related]
17. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
[TBL] [Abstract][Full Text] [Related]
18. Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy.
Adhikary D; Behrends U; Boerschmann H; Pfünder A; Burdach S; Moosmann A; Witter K; Bornkamm GW; Mautner J
PLoS One; 2007 Jul; 2(7):e583. PubMed ID: 17611619
[TBL] [Abstract][Full Text] [Related]
19. A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus.
Voisset C; Daskalogianni C; Contesse MA; Mazars A; Arbach H; Le Cann M; Soubigou F; Apcher S; Fåhraeus R; Blondel M
Dis Model Mech; 2014 Apr; 7(4):435-44. PubMed ID: 24558096
[TBL] [Abstract][Full Text] [Related]
20. Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion.
Rowe M; Glaunsinger B; van Leeuwen D; Zuo J; Sweetman D; Ganem D; Middeldorp J; Wiertz EJ; Ressing ME
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3366-71. PubMed ID: 17360652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
